Lantern Pharma Inc. - FORM S-1 - EX-3.1(II) - CERTIFICATE OF CONVERSION (DELAWARE) - April 16, 2020

Attached files

file filename
EX-10.10 - AMENDMENT NO. 2 TO DRUG LICENSE AND DEVELOPMENT AGREEMENT WITH ONCOLOGY VENTURE - Lantern Pharma Inc.ea120601fs1ex10-10_lantern.htm
S-1 - REGISTRATION STATEMENT - Lantern Pharma Inc.ea120601-s1_lanternpharma.htm
EX-23.1 - CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Lantern Pharma Inc.ea120601fs1ex23-1_lantern.htm
EX-21.1 - LIST OF SUBSIDIARY - Lantern Pharma Inc.ea120601fs1ex21-1_lantern.htm
EX-14.1 - CODE OF BUSINESS CONDUCT AND ETHICS - Lantern Pharma Inc.ea120601fs1ex14-1_lantern.htm
EX-10.12 - ADDENDUM TO TECHNOLOGYLICENSE AGREEMENT DATED FEBRUARY 8, 2016, WITH AF CHEMICAL - Lantern Pharma Inc.ea120601fs1ex10-12_lantern.htm
EX-10.11 - ASSIGNMENT AGREEMENTDATED AS OF JANUARY 5, 2018 WITH BIONUMERIK PHARMACEUTICALS, - Lantern Pharma Inc.ea120601fs1ex10-11_lantern.htm
EX-10.9 - ADDENDUM TO DRUG LICENSE AND DEVELOPMENT AGREEMENT WITH ONCOLOGY VENTURE A/S DAT - Lantern Pharma Inc.ea120601fs1ex10-9_lantern.htm
EX-10.8 - DRUG LICENSE AND DEVELOPMENT AGREEMENT DATED AS OF MAY 23, 2015 WITH ONCOLOGY VE - Lantern Pharma Inc.ea120601fs1ex10-8_lantern.htm
EX-10.7 - TECHNOLOGY LICENSE AGREEMENT DATED JANUARY 15,2015, WITH AF CHEMICALS LLC - Lantern Pharma Inc.ea120601fs1ex10-7_lantern.htm
EX-10.6 - AMENDED AND RESTATED VOTING AGREEMENT - Lantern Pharma Inc.ea120601fs1ex10-6_lantern.htm
EX-10.5 - AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT - Lantern Pharma Inc.ea120601fs1ex10-5_lantern.htm
EX-10.4 - AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT - Lantern Pharma Inc.ea120601fs1ex10-4_lantern.htm
EX-10.3 - FORM OF INDEMNIFICATION AGREEMENT - Lantern Pharma Inc.ea120601fs1ex10-3_lantern.htm
EX-10.2 - EMPLOYMENT AGREEMENT DATED JULY 23, 2018 WITH PANNA SHARMA - Lantern Pharma Inc.ea120601fs1ex10-2_lantern.htm
EX-10.1 - AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN - Lantern Pharma Inc.ea120601fs1ex10-1_lantern.htm
EX-4.1(III) - FORM OF WARRANT (2019) - Lantern Pharma Inc.ea120601fs1ex4-1iii_lantern.htm
EX-4.1(II) - FORM OF WARRANT (2017) - Lantern Pharma Inc.ea120601fs1ex4-1ii_lantern.htm
EX-4.1(I) - FORM OF WARRANT (2014) - Lantern Pharma Inc.ea120601fs1ex4-1i_lantern.htm
EX-3.1(IV) - BYLAWS - Lantern Pharma Inc.ea120601fs1ex3-1iv_lantern.htm
EX-3.1(III) - CERTIFICATE OF INCORPORATION - Lantern Pharma Inc.ea120601fs1ex3-1iii_lantern.htm
EX-3.1(I) - CERTIFICATE OF CONVERSION (TEXAS) - Lantern Pharma Inc.ea120601fs1ex3-1i_lantern.htm

Exhibit 3.1(ii)

 

Page 1

Delaware

The First State

 

I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF CONVERSION OF A TEXAS CORPORATION UNDER THE NAME OF “LANTERN PHARMA INC.” TO A DELAWARE CORPORATION, FILED IN THIS OFFICE ON THE FIFTEENTH DAY OF JANUARY, A.D. 2020, AT 10:38 O`CLOCK A.M.

 

A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE NEW CASTLE COUNTY RECORDER OF DEEDS.

 

 

     
   
   
   
7801204 8100F Authentication: 202196073
SR# 20200291615 Date: 01-15-20

You may verify this certificate online at corp.delaware.gov/authver.shtml

 

 

 

 

State of Delaware
Secretary of State
Division of Corporations
Delivered 10:38 AM 01/15/2020
FILED 10:38 AM 01/15/2020
SR 20200291615 - File Number 7801204		  

 

STATE OF DELAWARE
CERTIFICATE OF CONVERSION
FROM A NON-DELAWARE CORPORATION
TO A DELAWARE CORPORATION
PURSUANT TO SECTION 265 OF THE
DELAWARE GENERAL CORPORATION LAW

 

1.)The jurisdiction where the Non-Delaware Corporation first formed is Texas.

 

2.)The jurisdiction immediately prior to filing this Certificate is Texas.

 

3.)The date the Non-Delaware Corporation first formed is November 7, 2013.

 

4.)The name of the Non-Delaware Corporation immediately prior to filing this Certificate is Lantern Pharma Inc.

 

5.)The name of the Corporation as set forth in the Certificate of Incorporation is Lantern Pharma Inc.

 

IN WITNESS WHEREOF, the undersigned being duly authorized to sign on behalf of the converting Non-Delaware Corporation has executed this Certificate on the   14th   day of   January  , A.D.   2020  .

 

  By: /s/ Panna Sharma
  Name: Panna Sharma
  Title: President & Chief Executive Officer

 

 

 

Lantern Pharma Inc. Reports